Covered recipient · General Payments record
LAURIE A ROUSSEAU
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2025
$630.94
- Reported across 33 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.08 | 13 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $105.95 | 6 |
| Edwards Lifesciences Corporation | $30.84 | 1 |
| Acerta Pharma LLC | $29.14 | 2 |
| PFIZER INC. | $19.16 | 1 |
| Vanda Pharmaceuticals Inc. | $16.89 | 1 |
| Exact Sciences Corporation | $15.14 | 1 |
| Lilly USA, LLC | $13.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.35 | 04/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207015512 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.79 | 09/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206353423 | CMS |
| Edwards Lifesciences Corporation | $30.84 | 02/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225240797 | CMS |
| Exact Sciences Corporation | $15.14 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235265624 | CMS |
| Lilly USA, LLC | $13.96 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186711995 | CMS |
| Novo Nordisk Inc | $14.96 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188723684 | CMS |
| Novo Nordisk Inc | $21.15 | 04/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188616091 | CMS |
| Novo Nordisk Inc | $22.17 | 05/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188604400 | CMS |
| Novo Nordisk Inc | $15.53 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188887718 | CMS |
| Novo Nordisk Inc | $17.34 | 08/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188806161 | CMS |
| Novo Nordisk Inc | $14.80 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188340108 | CMS |
| PFIZER INC. | $19.16 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231669565 | CMS |
| Vanda Pharmaceuticals Inc. | $16.89 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232999440 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.